There Are Two Venture Markets Right Now

The headline number is real and it is staggering: $226B into AI in Q1 2026, the largest quarterly total ever recorded. But that headline obscures the story underneath it.

OpenAI's single round was $122B — 54% of the entire AI funding print for the quarter. Strip that one round out and the remaining $104B is roughly flat against Q4 2025 and meaningfully below the AI-quarter highs of 2024. The market is not booming. The market is concentrating.

That same concentration shows up in the YTD picture. Through April 2026, roughly 60% of all venture capital — across every sector, every stage, every geography — has flowed into just five companies. Anthropic. OpenAI. Jeff Bezos's Project Prometheus. Two others. Everything else, every other company on earth raising money, is splitting the remaining 40%.

So when we talk about "the venture market" right now, we are really talking about two markets:

The Large Cap Early Stage market — a handful of foundation-model labs and AI infrastructure plays, raising rounds that look more like sovereign-wealth allocations than venture financings. Multi-billion-dollar single checks. Pre-revenue valuations measured in the hundreds of billions. Capital sources that include corporate strategics, sovereign funds, and the largest crossover investors. This is not the venture asset class as it has historically been understood. It is something new.

The Small Cap Early Stage market — every other Series Seed, A, and B happening on the planet. This market is rational, disciplined, and in many sectors quietly compounding. Median round sizes are stable. Time between rounds is normalizing. Dilution discipline is back. The pricing excesses of 2021 are largely worked out.

These two markets share a name and almost nothing else. They have different LPs, different return profiles, different risk frameworks, and they will have different outcomes.

For founders building in the Small Cap Early Stage market — which is most founders — the macro signal worth tracking is not the headline AI number. It is what is happening to your stage in your sector. Which is, in most cases, healthier than the headlines suggest.

For LPs and allocators, the question is which of the two markets you are actually exposed to. They are not the same trade.